You just read:

Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation® Technology to Develop Long-Acting Asparaginase Product Candidates

News provided by

Jazz Pharmaceuticals plc

26 Jul, 2017, 21:05 BST